After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

On International Day of Radiology, Life Healthcare is spotlighting the critical role of PET-CT scans in cancer diagnosis and treatment, urging for their wider adoption across South Africa. PET-CT ...

Screening tests are designed to find cancers or precancers before they become lethal. But are prostate, lung, and breast ...

Hope Regional Medical Center in Panama City is now using a powerful new diagnostic tool in the fight against prostate cancer.

Two conditions may concur in increasing the incidence of BMs in CRPC patients treated with first-line docetaxel: the possibility for the patients of living longer than in the past and the ...

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

If you have any of these signs, you should see your doctor as soon as possible. Learn more about prostate cancer from the National Cancer Institute. Huntsman Cancer Institute’s Urologic Cancers ...

The new therapy combines two existing cancer drugs, enzalutamide and talazoparib. Enzalutamide, known by its brand name XTANDI, has been used as a treatment for metastatic castration-resistant ...

BM: Brain metastasis; CRPC: Castration-resistant prostate cancer; CT: Computed tomography; NA: Not assessed; NMR: Nuclear magnetic resonance; PC: Prostate cancer; S ...

test which may help detect early prostate cancer; If you have a raised PSA level, you may be offered an MRI scan of the prostate to help doctors decide if you need further tests and treatment.

has not been prospectively compared to planar bone scan plus CT. This was a single-arm, head-to-head, prospective phase II trial (NCT04928820) designed to enroll 102 men with prostate cancer who ...

David Kok has a clinical appointment at Peter MacCallum Cancer Centre which provides prostate cancer treatments including stereotactic radiotherapy, conventional radiotherapy and surgery.